Cart
sales@molnova.com
Sulfamerazine
CAS No. 127-79-7
Sulfamerazine( Sulfamerazine | Mebacid | Methylsulfadiazine )
Catalog No. M11153 CAS No. 127-79-7
Sulfamerazine(RP-2632) is a sulfonamide antibacterial.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 54 | In Stock |
|
| 1G | 90 | In Stock |
|
Biological Information
-
Product NameSulfamerazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfamerazine(RP-2632) is a sulfonamide antibacterial.
-
DescriptionSulfamerazine(RP-2632) is a sulfonamide antibacterial.(In Vitro):Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA.
-
In VitroSulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA.
-
In Vivo——
-
SynonymsSulfamerazine | Mebacid | Methylsulfadiazine
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorDHPS
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number127-79-7
-
Formula Weight264.3
-
Molecular FormulaC11H12N4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 53 mg/mL (200.52 mM)
-
SMILESO=S(C1=CC=C(N)C=C1)(NC2=NC=CC(C)=N2)=O
-
Chemical Name4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ATG7-IN-1
ATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
-
Ammonium Chloride
Ammonium chloride acts as a small molecule autophagy inhibitor.Ammonium chloride is a pH-regulating, heteropolar compound that can cause intracellular alkalosis and metabolic acidosis, thereby affecting enzyme activity and influencing processes in biological systems.
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
